Cargando…
Towards the Molecular Foundations of Glutamatergic-targeted Anti-depressants
BACKGROUND: Depression affects over 120 million individuals of all ages and is the leading cause of disability worldwide. The lack of objective diagnostic criteria, together with the heterogeneity of the depressive disorder itself, makes it challenging to develop effective therapies. The accumulatio...
Autores principales: | Kroes, Roger A., Nilsson, Carol L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327457/ https://www.ncbi.nlm.nih.gov/pubmed/26955966 http://dx.doi.org/10.2174/1570159X14666160309114740 |
Ejemplares similares
-
Zinc in the Glutamatergic Theory of Depression
por: Młyniec, Katarzyna
Publicado: (2015) -
Targeted sensors for glutamatergic neurotransmission
por: Hao, Yuchen, et al.
Publicado: (2023) -
Alzheimer’s disease: targeting the glutamatergic system
por: Conway, Myra E.
Publicado: (2020) -
Reduced adaptation of glutamatergic stress response is associated with pessimistic expectations in depression
por: Cooper, Jessica A., et al.
Publicado: (2021) -
An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents
por: Lewis, Charles P., et al.
Publicado: (2016)